Created with Sketch.
Medsider: Learn from MedTech and HealthTech Experts
47 minutes | Aug 20, 2020
How to Win with Contract Manufacturers: Interview with Travis Sessions, CEO of Biomerics
On this episode of Medsider Radio, our guest is Travis Sessions, the Founder and Chief Executive Officer of Biomerics, a leading mid-market interventional device contract manufacturer. He's also a Managing Partner of Med Venture Holdings, a unique medtech growth equity investor. With over 20 years of business management experience, Travis has successfully built and grown multiple medical device technology companies during his career. He got his start professionally at Dow Chemical and has held management positions at Microsoft and Parker Hannifin Corporation. Travis has a B.S. in Chemical Engineering from Brigham Young University and a Master’s in Business Administration from the University of Michigan. Interview Highlights with Travis Sessions:Macro trends within the medtech market, including Travis’ thoughts on the future.Key differences between contract manufacturers (CMs) and large original equipment manufacturers (OEMs).Critical things that OEMs should look for when identifying and working with CMs.The origin story of Med Venture Holdings.What Travis looks for when vetting early-stage medtech ideas.Critical functions that need to be in place for a medical device startup to be acquired.Travis’ favorite book, the mentor he most admires, and the advice he’d give to his 30-year-old self.Learn more...
60 minutes | Jul 22, 2020
Clinical Trials as Revenue Drivers: Interview with Matthew Amsden, CEO of ProofPilot
In this episode of Medsider Radio, our guest is Matthew Amsden, the Founder and CEO of ProofPilot, a platform designed to help people design, launch and participate in clinical trials.ProofPilot’s mission statement revolves around making it incredibly easy to run scientifically-valid research studies. They’re dedicated to making research study participation accessible, interesting, and fun. In this discussion with Matthew, we chatted about the importance and feasibility of virtual clinical trials, how they can potentially become a revenue driver, the origin story of ProofPilot, and why their hybrid model is so popular.Interview Highlights with Matthew AmsdenWho is Matthew Amsden and where did the idea for ProofPilot begin? The importance of letting early customers try product iterations.How clinical studies can become a revenue driver. Various types of clinical trials and how they’re conducted on the ProofPilot platform.Risky and costly approaches to traditional clinical studies. The synergy between data, compliance, and incentives.How a virtual, hybrid model can solve problems when it comes to traditional clinical trials. Matthew’s favorite business book, the mentor he most admires, and the advice he’d give to his 30-year-old-self.See more...
51 minutes | Jul 15, 2020
Why Practicing Strategic Patience is Critical for Medtech Entrepreneurs: Interview with Dr. Tej Singh, Founder of Fist Assist Devices
Over the last 20 years, Dr. Tej Singh has served as the Founder and Chief of Vascular Surgery for three large, multidisciplinary vascular programs in Silicon Valley. He has vast experience with renal failure and vascular access procedures, and is acutely focused on his first company, Fist Assist Devices. Dr. Singh’s company is developing the first renal care wearable device for venous enlargement and dialysis enhancement. In this episode, Dr. Singh and I talk about the primary challenge that Fist Assist Devices is trying to solve, the origin story for their first product, his approach to mapping out clinical trial strategies, and much more. Interview Highlights with Dr. Tej SinghWho is Dr. Tej Singh and what is his background?What is Fist Assist Devices and what challenges are they trying to solve?The origin story for their first product and the critical inflection points for the company. How Dr. Singh evaluated the IP landscape for his first device. Dr. Singh’s approach to mapping out clinical trial strategies.How he navigated the insurance coverage and reimbursement landscape.His unique approach to strategic patience and why it’s crucial for medtech startups.Dr. Singh’s favorite book, the leader he most admires, and the advice he’d give to his 30-year-old self.See more...
46 minutes | Jul 9, 2020
How Remote Testing Can Change the Game for Patients and Clinicians: Interview with Katherine Ward of Healthy.io
I recently sat down with Katherine Ward, Chief Commercial Officer and managing director for Healthy.io. She has worked in healthcare for 28 years — including 15 years with the UK National Health Service and 11 years with United Health Group where she was the Chief Executive with United Health UK and Chief Growth Officer with Optimum International. In this conversation, we cover what Healthy.io does for the broader healthcare community, lessons from the COVID-19 crisis, clinical-grade population health technology, decentralized remote diagnostic screening, and how their technology works with existing health systems. Interview Highlights with Katherine WardWho is Katherine and what is her background?What is Healthy.io and what challenges or problems do they solve for patients and clinicians?Why the time finally come for decentralized remote diagnostic screening, using urine testing as an example.Lessons on the importance of virtual testing from the COVID-19 crisis.How Healthy.io has approached the regulatory and reimbursement landscapes, including their clinical trial strategy.How their population health technology works together (with and within) existing healthcare systems.Katherine’s favorite genre of books, the leader she most admires, and the advice she’d give to her younger self.See more...
40 minutes | May 22, 2020
How Medtech Companies Can Enhance Procedural Workflow and Capture Intra-Operative Data: Interview with Jennifer Fried, CEO of ExplORer Surgical
In this episode of Medsider Radio, we downloaded with Jennifer Fried, the CEO and Co-Founder of ExplORer Surgical. Jennifer founded the company with Dr. Alex Langerman as an MBA student at the University of Chicago Booth School of Business, where she received her degree with honors in finance and entrepreneurship.Previously, Jennifer was a Vice President at Park Lane Ventures, a healthcare-focused venture capital fund spun out of Essex Woodlands. Jennifer began her career as a consultant at Bain & Company in Chicago after graduating from Northwestern University.With me on this episode is special guest host, Norbert Juist, who runs Sales Performance Resources, where he specializes in recruiting for medical device marketing and sales positions. Prior to this, he was a sales rep at Cordis Endovascular, a spine consultant at Synthes, and a sales rep at Ethicon. Interview Highlights with Jennifer Fried● How most medical device companies capture procedural data & workflow processes -- and why it’s completely outdated. ● The challenges medtech companies are facing when it comes to educational training & product development and why they’re considering platforms like ExplORer Surgical.● Jennifer’s favorite business book, the business leader she most admires, and the advice she’d give to herself 5-10 years ago.See more...
49 minutes | May 2, 2020
How to Use Checks and Balances in Your Medtech Start-Up: Interview with Michael Tozzi, President and CEO of TAS Medical
On this episode of Medsider Radio, I had the chance to sit down with Michael Tozzi, President and CEO of TAS Medical. Mike and his team are aiming to eliminate surgical mesh by converting hernia procedures to minimally invasive repairs.Mike has over 20 years of commercial medical device experience and specializes in investor relations, sales & marketing readiness, and improving the execution of early-stage medical device companies.. Previous to TAS Medical, Mike served as Chief Commercial Officer at Carevoyance, where he and his team created groundbreaking analytics tools designed to help medical device companies better understand their markets and execute their commercial goals.Prior to this, Mike helped to build Cardiovascular Systems, Inc. (or CSI) from the ground floor, taking the company from early stage to over $1.3 billion in market capitalization in just seven years. At CSI, Mike held various executive roles in sales and marketing. Joining me on this episode is special guest host, Norbert Juist, who runs Sales Performance Resources, which specializes in recruiting for medtech marketing and sales positions. Prior to this, he was a sales rep at Cordis Endovascular, a spine consultant at Synthes, and a sales rep at Ethicon. Interview Highlights with Mike TozziThe origin story of TAS Medical and how Mike got involved.The strategies that TAS Medical followed to go from initial product concept to eventual commercialization.The regulatory and clinical paths that Mike and his team considered.How much the insurance coverage and reimbursement landscape factored into Mike’s early decision-making process.Mike’s approach to raising capital for CSI and TAS Medical. Common mistakes that early-stage medtech companies make and how to avoid them.Mike’s favorite book, the business leader he most admires, and the advice he’d give to his 30-year old self.See more...
49 minutes | Apr 24, 2020
Resiliency and Relentlessness are Crucial for Raising Medtech Capital: Interview with Beverly Huss, President and CEO of Qool Therapeutics
Joining Medsider Radio for this episode is Beverly Huss, President and CEO of Qool Therapeutics, a development-stage company working on a novel, non-invasive therapeutic hypothermia device for the preservation of tissue following catastrophic events like a heart attack, stroke, or traumatic brain injury.Previously, Beverly was the CEO of Vibrynt, a start-up medical device company dedicated to creating minimally invasive therapies for patients suffering from morbid obesity. Prior to that, Beverly was the President of Guidant Endovascular Solutions (acquired by Abbott), a medical device company focused on the treatment of cardiovascular and peripheral vascular disease.She holds an M.S. in technology management from Pepperdine University, as well as a B.S. in metallurgical engineering from the University of Illinois. Beverly also has a few patents to her credit in the cardiovascular and obesity medical device arenas.With me on this episode is guest host, Norbert Juist, one of the most honest, genuine, and personable people I know. Norbert runs Sales Performance Resources, where he specializes in recruiting for medtech marketing and sales positions. Prior to this, he was a sales rep at Cordis Endovascular, a spine consultant at Synthes, and a sales rep at Ethicon. Interview Highlights with Beverly HussThe origin story of Qool Therapeutics and how Beverly got involved with the company.The clinical trial strategy that Qool Therapeutics is following and the reasoning for it.Beverly’s strategic approach to making a medical device a reality, including the regulatory, clinical, and reimbursement paths that should be considered.Key learnings from Beverly’s time at Vibrynt. The “other R&R”: the importance of resilience and relentlessness when you are raising money for a company.How to get the attention of medical device venture capitalists.Critical lessons Beverly throughout her career at ACS and Guidant.Beverly’s favorite books and how they inspire resiliency.The business leaders and mentors that Beverly most admires.Advice Beverly would give to her 30-year old self.See more...
50 minutes | Mar 12, 2020
Essential Tips for First-Time Medtech CEOs: Interview with Dan Rose, CEO of LimFlow
I recently had the opportunity to interview Dan Rose, CEO of the French-based medtech company LimFlow. Founded in 2012, LimFlow transformed the peripheral vasculature space by providing a lifesaving option for end-stage critical limb-threatening ischemia (CLTI) patients facing amputation. LimFlow is designed to restore blood flow to the ischemic foot via deep vein arterialization, thereby preventing major amputation, resolving pain, and promoting wound healing. Prior to assuming the role of CEO at LimFlow in August 2016, Dan had more than 16 years of leadership experience in the medical device and venture capital/startup sectors. Most recently, he was VP and General Manager EMEA for Direct Flow Medical, and VP of Commercial Operations and a Member of the Board at Sequana Medical, a Swiss medical device company. Norbert Juist, an executive recruiter who specializes in medical device sales and marketing, also joined me for this interview with Dan Rose. Norbert brings a unique perspective to this discussion, having worked as a sales rep and consultant in medtech for nearly 20 years prior to transitioning to executive recruiting.Here are a few of the topics we discuss in this episode:How LimFlow used a concept that’s been in existence since 1912 and transformed it into a modern therapy that multidisciplinary clinicians can reproduce.How Med Start played an instrumental role in the launch and ultimate success of LimFlow.Why it’s essential to find a physician champion willing to invest time and energy in your tech.Overcoming the challenges presented by an ever-evolving MDR landscape, both in the EU and US.Key factors you can’t ignore if you want to succeed as a first-time CEO.Why investing in independent market research is well worth the cost.Why the FDA Breakthrough Devices Program has been a game changer in the US.See more...
53 minutes | Mar 4, 2020
How Failure and Flexibility Can Spell Success in Medtech: Interview With Kyle Frye, U.S. President of SyntheticMR
After a brief hiatus from recording podcasts, it was a privilege to dust off the microphone and interview Kyle Frye. As U.S. president of SyntheticMR, Kyle is tasked with growing and expanding the brand and business in the U.S. for the Swedish-based company that is creating the future of quantitative MRI technology. Their innovative MRI software solutions support shorter exam times and deliver more information to clinicians, leading to improved diagnostic efficacies.Prior to assuming this role in August 2019, Kyle was a Zone Vice President of Sales for Siemens, and also was in leadership positions at both niche and large medtech companies including Blue Belt Technologies (now Smith & Nephew), Verathon, and Brainlab. He also worked for BioMedix for three years, working his way up from a sales rep driving 4–5 hours a day to Western Area Sales Director, which required relocation from metro Cincinnati to the San Francisco Bay area. Kyle received a B.A. degree in political science and finance from Northern Kentucky University in 2004.Norbert Juist, an executive recruiter who specializes in medical device sales and marketing, joined me as a special guest for this interview with Kyle. He brings a unique perspective to this discussion, having worked as a sales rep and consultant in pharma and medtech for nearly 20 years prior to transitioning to recruiting.Here are a few of the key topics we discussed in this podcast: Why a competitive spirit and winning are important, but not the “be-all and end-all” to medical device success.Why communicating “the why” of career moves is key to landing new opportunities.How being flexible and willing to relocate can help advance your career, especially in the medtech space.The pros and cons of working for large vs. small companies.Kyle’s favorite business books, the importance of having a mentor, and the advice he would tell his 25-year-old self.Check out the rest of the show notes here...
58 minutes | Feb 8, 2020
Ruthless Prioritization and How it Can Help Every Medtech Startup: Interview With Paul Buckman Former CEO of Conventus, SentreHEART, and Pathway Medical Technologies
A few years ago, I had the privilege of sitting down and talking with serial medtech entrepreneur Paul Buckman, who at the time, was CEO of Conventus Orthopedics. Prior to Conventus, Paul held CEO roles at SentreHEART, Pathway Medical Technologies (which sold to Bayer HealthCare), and Devax (which sold to Biosensors International). From 2004 through 2006, Buckman served as President of the Cardiology Division of St. Jude Medical. Before joining St. Jude, he served as Chairman and CEO of ev3, a company that Buckman co-founded and was later acquired by Covidien for $2.5 billion dollars in 2010.Paul has worked in the medical device industry for over 35 years, including 10 years at Scimed Life Systems and Boston Scientific where he held several executive positions before becoming President of the Cardiology Division at Boston Scientific in January of 2000. Buckman received a BA degree in business administration and an MBA degree from Western Michigan University. Here are a few of the things we’re going to learn in this interview with Paul:- Of all the medtech startups that Paul’s been a part of, the two that are closest to his heart.- Two of the many key learnings that Paul recalls during his time helping to build Scimed.- When it comes to product development for medtech startups, why it’s critical to be ruthless about prioritization.See more...
42 minutes | Feb 8, 2020
How to Move Forward After a Thumbs Down from FDA: Interview with Kevin Sidow, Former CEO and President of Moximed
In late 2016, I was able to sit down with Kevin Sidow. At the time he was President & Chief Executive Officer for Moximed, and had been since 2008.Prior to his time at Moximed, Kevin was President & CEO for St. Francis Medical Technologies, a privately held, venture-funded company focused on developing innovative treatments for patients suffering from degenerative spinal disorders. In January 2007, St. Francis Medical Technologies was sold for $725 million to Kyphon, which was acquired by Medtronic later that same year.Previously, Kevin was the Worldwide President of DePuy, where he supervised the global orthopedic, spine, trauma, and sports medicine businesses, with annual revenue responsibility of over $3 billion dollars. Kevin holds a B.S. in Accounting from West Virginia University.Here are a few of the things we learned from Kevin:- How Kevin felt when Moximed’s first patient was treated with the Atlas System after 8+ years of research and development.- What makes the Atlas System different than other orthopedic knee implants.- How medtech professionals looking to take the next step in their career can utilize Kevin’s advice and learn from his meteoric rise to Worldwide President of DePuy.See more...
72 minutes | Jan 17, 2020
Why Keeping The End in Mind is Critical for Every Medtech Entrepreneur: Interview with Erica Rogers, CEO of Silk Road Medical
In this two-part interview, I was lucky enough to sit down with Erica Rogers, CEO of Silk Road Medical. We first spoke a few years ago and then again much more recently to catch up on what had changed at Silk Road since our first conversation.During our catch up, we discussed how Erica led her team at Silk Road through PMA approval, successful insurance coverage and reimbursement strategy, which led to a very rewarding public offering for Silk Road, opening at $20 a share. This resulted in the opportunity to continue the company’s goal, which is to change the standard of care in carotid artery disease with their TCAR procedure.Much of our first conversation was about Erica’s career trajectory and how she was able to successfully, and gracefully, exit multiple medtech companies. Her lengthy career and insight as a medtech thought leader is just as interesting today as it was when we recorded our conversation.Before leading Silk Road, Erica was the COO of Medicines360, a nonprofit pharmaceutical company developing drugs and devices for women. Erica was the founder and CEO of Allux Medical as well as the cofounder of Visiogen, which was acquired by Abbott Medical Optics in 2009.Prior to that, Erica spent over 12 years at Boston Scientific in a variety of sales and marketing positions. She began her career in pharmaceutical sales after receiving a B.S. in Zoology from San Diego State University. Erica holds five issued and 15 pending US patents for medical devices in nanotechnology. See more...
Terms of Service
Do Not Sell My Personal Information
© Stitcher 2022